{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T03:21:00Z","timestamp":1790824860326,"version":"4.1.0"},"reference-count":99,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["atherosclerosis-journal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.atherosclerosis.2020.06.003","type":"journal-article","created":{"date-parts":[[2020,7,3]],"date-time":"2020-07-03T02:43:05Z","timestamp":1593744185000},"page":"80-86","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":104,"special_numbering":"C","title":["Tissue factor in atherosclerosis and atherothrombosis"],"prefix":"10.1016","volume":"307","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8709-8394","authenticated-orcid":false,"given":"Steven P.","family":"Grover","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigel","family":"Mackman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2020.06.003_bib1","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1161\/ATVBAHA.117.309846","article-title":"Tissue factor: an essential mediator of hemostasis and trigger of thrombosis","volume":"38","author":"Grover","year":"2018","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2020.06.003_bib2","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1172\/JCI119765","article-title":"Tissue factor expression in human arterial smooth muscle cells. TF is present in three cellular pools after growth factor stimulation","volume":"100","author":"Schecter","year":"1997","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.atherosclerosis.2020.06.003_bib3","first-page":"1087","article-title":"Selective cellular expression of tissue factor in human tissues. Implications for disorders of hemostasis and thrombosis","volume":"134","author":"Drake","year":"1989","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.atherosclerosis.2020.06.003_bib4","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/S0002-9440(10)61204-7","article-title":"Tissue factor-dependent coagulation is preferentially up-regulated within arterial branching areas in a baboon model of Escherichia coli sepsis","volume":"167","author":"Lupu","year":"2005","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.atherosclerosis.2020.06.003_bib5","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1111\/j.1538-7836.2007.02576.x","article-title":"Tissue factor around dermal vessels has bound factor VII in the absence of injury","volume":"5","author":"Hoffman","year":"2007","journal-title":"J. Thromb. Haemostasis"},{"key":"10.1016\/j.atherosclerosis.2020.06.003_bib6","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1161\/01.ATV.0000168413.29874.d7","article-title":"Intracellular and surface distribution of monocyte tissue factor: application to intersubject variability","volume":"25","author":"Egorina","year":"2005","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2020.06.003_bib7","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1038\/nm1104-1155b","article-title":"Active tissue factor in blood?","volume":"10","author":"Butenas","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.atherosclerosis.2020.06.003_bib8","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.1182\/blood-2004-09-3567","article-title":"Tissue factor activity in whole blood","volume":"105","author":"Butenas","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.atherosclerosis.2020.06.003_bib9","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1084\/jem.174.6.1517","article-title":"Lipopolysaccharide-mediated transcriptional activation of the human tissue factor gene in THP-1 monocytic cells requires both activator protein 1 and nuclear factor kappa B binding sites","volume":"174","author":"Mackman","year":"1991","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.atherosclerosis.2020.06.003_bib10","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S1050-1738(98)00002-4","article-title":"NF-\u03baB mediated transcription in human monocytic cells and endothelial cells","volume":"8","author":"Parry","year":"1998","journal-title":"Trends Cardiovasc. Med."},{"key":"10.1016\/j.atherosclerosis.2020.06.003_bib11","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1073\/pnas.86.8.2839","article-title":"Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque","volume":"86","author":"Wilcox","year":"1989","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.atherosclerosis.2020.06.003_bib12","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1586\/erc.11.40","article-title":"The missing link between atherosclerosis, inflammation and thrombosis: is it tissue factor?","volume":"9","author":"Cimmino","year":"2011","journal-title":"Expert Rev. Cardiovasc Ther."},{"key":"10.1016\/j.atherosclerosis.2020.06.003_bib13","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1161\/01.CIR.91.3.619","article-title":"Differential expression of tissue factor protein in directional atherectomy specimens from patients with stable and unstable coronary syndromes","volume":"91","author":"Annex","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2020.06.003_bib14","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1161\/01.CIR.94.6.1226","article-title":"Identification of active tissue factor in human coronary atheroma","volume":"94","author":"Marmur","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2020.06.003_bib15","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S0140-6736(96)11189-2","article-title":"Tissue-factor antigen and activity in human coronary atherosclerotic plaques","volume":"349","author":"Ardissino","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2020.06.003_bib16","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0021-9150(97)00132-9","article-title":"Localization and activity of tissue factor in human aortic atherosclerotic lesions","volume":"133","author":"Hatakeyama","year":"1997","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2020.06.003_bib17","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1161\/01.ATV.17.10.2232","article-title":"Tissue factor expression on macrophages in coronary plaques in patients with unstable angina","volume":"17","author":"Kaikita","year":"1997","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2020.06.003_bib18","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/BF00193948","article-title":"Ultrastructural localization of tissue factor on monocyte-derived macrophages and macrophage foam cells associated with atherosclerotic lesions","volume":"425","author":"Landers","year":"1994","journal-title":"Virchows Arch."},{"key":"10.1016\/j.atherosclerosis.2020.06.003_bib19","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1055\/s-0037-1614527","article-title":"Increased thrombogenic potential of human monocyte-derived macrophages spontaneously transformed into foam cells","volume":"81","author":"Colli","year":"1999","journal-title":"Thromb. Haemostasis"},{"key":"10.1016\/j.atherosclerosis.2020.06.003_bib20","doi-asserted-by":"crossref","first-page":"10370","DOI":"10.1073\/pnas.89.21.10370","article-title":"Uptake of exogenous free cholesterol induces upregulation of tissue factor expression in human monocyte-derived macrophages","volume":"89","author":"Lesnik","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.atherosclerosis.2020.06.003_bib21","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1172\/JCI110201","article-title":"Plasma lipoprotein induction and suppression of the generation of cellular procoagulant activity in vitro: two procoagulant activities are produced by peripheral blood mononuclear cells","volume":"67","author":"Schwartz","year":"1981","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.atherosclerosis.2020.06.003_bib22","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1016\/0167-5273(94)90322-0","article-title":"Effect of lipoproteins on tissue factor activity and PAI-II antigen in human monocytes and macrophages","volume":"47","author":"Wada","year":"1994","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2020.06.003_bib23","first-page":"1029","article-title":"Procoagulant activity after exposure of monocyte-derived macrophages to minimally oxidized low density lipoprotein. Co-localization of tissue factor antigen and nascent fibrin fibers at the cell surface","volume":"147","author":"Lewis","year":"1995","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.atherosclerosis.2020.06.003_bib24","doi-asserted-by":"crossref","first-page":"596","DOI":"10.5551\/jat.7179","article-title":"Dose-dependent modulation of tissue factor protein and procoagulant activity in human monocyte-derived macrophages by oxidized low density lipoprotein","volume":"18","author":"Meisel","year":"2011","journal-title":"J. Atherosclerosis Thromb."},{"key":"10.1016\/j.atherosclerosis.2020.06.003_bib25","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1161\/01.ATV.17.10.1901","article-title":"Dysregulation of monocytic nuclear factor-kappa B by oxidized low-density lipoprotein","volume":"17","author":"Brand","year":"1997","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2020.06.003_bib26","first-page":"601","article-title":"Minimally oxidized low-density lipoprotein induces tissue factor expression in cultured human endothelial cells","volume":"138","author":"Drake","year":"1991","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.atherosclerosis.2020.06.003_bib27","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1093\/cvr\/cvz230","article-title":"Oxidized low-density lipoproteins induce tissue factor expression in T-lymphocytes via activation of lectin-like oxidized low-density lipoprotein receptor-1","volume":"116","author":"Cimmino","year":"2019","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.atherosclerosis.2020.06.003_bib28","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/S0140-6736(05)63452-6","article-title":"Simvastatin reduces monocyte-tissue-factor expression type IIa hypercholesterolaemia","volume":"350","author":"Ferro","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2020.06.003_bib29","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jacc.2004.09.047","article-title":"CD40 ligand enhances monocyte tissue factor expression and thrombin generation via oxidative stress in patients with hypercholesterolemia","volume":"45","author":"Sanguigni","year":"2005","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2020.06.003_bib30","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1172\/JCI58969","article-title":"Monocyte tissue factor-dependent activation of coagulation in hypercholesterolemic mice and monkeys is inhibited by simvastatin","volume":"122","author":"Owens","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.atherosclerosis.2020.06.003_bib31","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s102380300015","article-title":"Different effect induced by treatment with several statins on monocyte tissue factor expression in hypercholesterolemic subjects","volume":"3","author":"Bruni","year":"2003","journal-title":"Clin. Exp. Med."},{"key":"10.1016\/j.atherosclerosis.2020.06.003_bib32","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.thromres.2016.01.011","article-title":"Measurement of microparticle tissue factor activity in clinical samples: a summary of two tissue factor-dependent FXa generation assays","volume":"139","author":"Hisada","year":"2016","journal-title":"Thromb. Res."},{"key":"10.1016\/j.atherosclerosis.2020.06.003_bib33","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1161\/01.CIR.99.3.348","article-title":"Shed membrane microparticles with procoagulant potential in human atherosclerotic plaques: a role for apoptosis in plaque thrombogenicity","volume":"99","author":"Mallat","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2020.06.003_bib34","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.jacc.2006.10.053","article-title":"Cellular origins and thrombogenic activity of microparticles isolated from human atherosclerotic plaques","volume":"49","author":"Leroyer","year":"2007","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2020.06.003_bib35","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1161\/01.CIR.98.11.1051","article-title":"Presence of tissue factor pathway inhibitor in human atherosclerotic plaques is associated with reduced tissue factor activity","volume":"98","author":"Caplice","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2020.06.003_bib36","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1161\/01.ATV.20.5.1362","article-title":"Expression, localization, and activity of tissue factor pathway inhibitor in normal and atherosclerotic human vessels","volume":"20","author":"Crawley","year":"2000","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2020.06.003_bib37","doi-asserted-by":"crossref","first-page":"e134","DOI":"10.1016\/j.thromres.2011.11.044","article-title":"Circulating monocytes mirror the imbalance in TF and TFPI expression in carotid atherosclerotic plaques with lipid-rich and calcified morphology","volume":"129","author":"Basavaraj","year":"2012","journal-title":"Thromb. Res."},{"key":"10.1016\/j.atherosclerosis.2020.06.003_bib38","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1021\/bi951501d","article-title":"Inhibitory properties of a novel human Kunitz-type protease inhibitor homologous to tissue factor pathway inhibitor","volume":"35","author":"Petersen","year":"1996","journal-title":"Biochemistry"},{"key":"10.1016\/j.atherosclerosis.2020.06.003_bib39","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1161\/hq0102.101842","article-title":"Expression and localization of tissue factor pathway inhibitor-2 in normal and atherosclerotic human vessels","volume":"22","author":"Crawley","year":"2002","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2020.06.003_bib40","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1161\/ATVBAHA.111.237693","article-title":"Animal models of atherosclerosis","volume":"32","author":"Getz","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2020.06.003_bib41","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/0049-3848(96)00083-7","article-title":"Enhanced expression of tissue factor activity in the atherosclerotic aortas of cholesterol-fed rabbits","volume":"82","author":"Kato","year":"1996","journal-title":"Thromb. Res."},{"key":"10.1016\/j.atherosclerosis.2020.06.003_bib42","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.atherosclerosis.2009.03.014","article-title":"Thrombin generation by intimal tissue factor contributes to thrombus formation on macrophage-rich neointima but not normal intima of hyperlipidemic rabbits","volume":"206","author":"Yamashita","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2020.06.003_bib43","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1161\/01.CIR.100.11.1215","article-title":"Dietary lipid lowering reduces tissue factor expression in rabbit atheroma","volume":"100","author":"Aikawa","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2020.06.003_bib44","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0021-9150(02)00387-8","article-title":"Simvastatin inhibits expression of tissue factor in advanced atherosclerotic lesions of apolipoprotein E deficient mice independently of lipid lowering: potential role of simvastatin-mediated inhibition of Egr-1 expression and activation","volume":"167","author":"Bea","year":"2003","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2020.06.003_bib45","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1161\/01.ATV.0000202028.62414.3c","article-title":"Atherosclerosis in mice is not affected by a reduction in tissue factor expression","volume":"26","author":"Tilley","year":"2006","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2020.06.003_bib46","doi-asserted-by":"crossref","first-page":"3044","DOI":"10.1161\/hc2501.092492","article-title":"Deficiency of tissue factor pathway inhibitor promotes atherosclerosis and thrombosis in mice","volume":"103","author":"Westrick","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2020.06.003_bib47","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.ijcard.2016.11.195","article-title":"Conditional knockout of TFPI-1 in VSMCs of mice accelerates atherosclerosis by enhancing AMOT\/YAP pathway","volume":"228","author":"Xiao","year":"2017","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2020.06.003_bib48","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1161\/CIRCRESAHA.109.195016","article-title":"Vascular-directed tissue factor pathway inhibitor overexpression regulates plasma cholesterol and reduces atherosclerotic plaque development","volume":"105","author":"Pan","year":"2009","journal-title":"Circ. Res."},{"key":"10.1016\/j.atherosclerosis.2020.06.003_bib49","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1161\/CIRCULATIONAHA.114.013423","article-title":"Expression of human tissue factor pathway inhibitor on vascular smooth muscle cells inhibits secretion of macrophage migration inhibitory factor and attenuates atherosclerosis in ApoE-\/- mice","volume":"131","author":"Chen","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2020.06.003_bib50","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1016\/j.ijcard.2013.03.073","article-title":"Over-expression of TFPI-2 promotes atherosclerotic plaque stability by inhibiting MMPs in apoE-\/- mice","volume":"168","author":"Pan","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2020.06.003_bib51","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.thromres.2015.11.010","article-title":"Conditional knockout of tissue factor pathway inhibitor 2 in vascular endothelial cells accelerates atherosclerotic plaque development in mice","volume":"137","author":"Hong","year":"2016","journal-title":"Thromb. Res."},{"key":"10.1016\/j.atherosclerosis.2020.06.003_bib52","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1055\/s-0038-1650283","article-title":"Tissue factor induces migration of cultured aortic smooth muscle cells","volume":"75","author":"Sato","year":"1996","journal-title":"Thromb. Haemostasis"},{"key":"10.1016\/j.atherosclerosis.2020.06.003_bib53","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1161\/01.CIR.0000129312.43547.08","article-title":"Tissue factor binding of activated factor VII triggers smooth muscle cell proliferation via extracellular signal-regulated kinase activation","volume":"109","author":"Cirillo","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2020.06.003_bib54","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1161\/01.CIR.0000153333.52294.42","article-title":"Tissue factor cytoplasmic domain stimulates migration by activation of the GTPase Rac1 and the mitogen-activated protein kinase p38","volume":"111","author":"Ott","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2020.06.003_bib55","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1160\/TH04-02-0122","article-title":"Mice deficient in tissue factor demonstrate attenuated intimal hyperplasia in response to vascular injury and decreased smooth muscle cell migration","volume":"92","author":"Pyo","year":"2004","journal-title":"Thromb. Haemostasis"},{"key":"10.1016\/j.atherosclerosis.2020.06.003_bib56","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0049-3848(02)00345-6","article-title":"Protease-activated receptor 2 (PAR2) mediates vascular smooth muscle cell migration induced by tissue factor\/factor VIIa complex","volume":"107","author":"Marutsuka","year":"2002","journal-title":"Thromb. Res."},{"key":"10.1016\/j.atherosclerosis.2020.06.003_bib57","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1111\/j.1538-7836.2012.04910.x","article-title":"Subcellular localization of tissue factor and human coronary artery smooth muscle cell migration","volume":"10","author":"Pe\u00f1a","year":"2012","journal-title":"J. Thromb. Haemostasis"},{"key":"10.1016\/j.atherosclerosis.2020.06.003_bib58","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.atherosclerosis.2010.07.017","article-title":"Tissue Factor-Factor VIIa complex induces cytokine expression in coronary artery smooth muscle cells","volume":"212","author":"Demetz","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2020.06.003_bib59","doi-asserted-by":"crossref","first-page":"84","DOI":"10.3389\/fcvm.2017.00084","article-title":"An interleukin-6 receptor antibody suppresses atherosclerosis in atherogenic mice","volume":"4","author":"Akita","year":"2017","journal-title":"Front Cardiovasc. Med."},{"key":"10.1016\/j.atherosclerosis.2020.06.003_bib60","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1172\/JCI1195","article-title":"A leukocyte homologue of the IL-8 receptor CXCR-2 mediates the accumulation of macrophages in atherosclerotic lesions of LDL receptor-deficient mice","volume":"101","author":"Boisvert","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.atherosclerosis.2020.06.003_bib61","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.tcm.2013.07.003","article-title":"Hyperlipidemia, tissue factor, coagulation, and simvastatin","volume":"24","author":"Owens","year":"2014","journal-title":"Trends Cardiovasc. Med."},{"key":"10.1016\/j.atherosclerosis.2020.06.003_bib62","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1161\/01.CIR.103.2.276","article-title":"An HMG-CoA reductase inhibitor, cerivastatin, suppresses growth of macrophages expressing matrix metalloproteinases and tissue factor in vivo and in vitro","volume":"103","author":"Aikawa","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2020.06.003_bib63","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1161\/01.ATV.0000030360.72503.56","article-title":"Statins reduce inflammation in atheroma of nonhuman primates independent of effects on serum cholesterol","volume":"22","author":"Sukhova","year":"2002","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2020.06.003_bib64","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1160\/TH05-04-0245","article-title":"Pravastatin reduces thrombogenicity by mechanisms beyond plasma cholesterol lowering","volume":"94","author":"Casani","year":"2005","journal-title":"Thromb. Haemostasis"},{"key":"10.1016\/j.atherosclerosis.2020.06.003_bib65","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1161\/ATVBAHA.118.311655","article-title":"Roles of coagulation proteases and PARs (Protease-Activated receptors) in mouse models of inflammatory diseases","volume":"39","author":"Posma","year":"2019","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2020.06.003_bib66","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.atherosclerosis.2015.03.023","article-title":"Rivaroxaban, a novel oral anticoagulant, attenuates atherosclerotic plaque progression and destabilization in ApoE-deficient mice","volume":"242","author":"Hara","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2020.06.003_bib67","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/432080","article-title":"Evaluation of plaque stability of advanced atherosclerotic lesions in apo E-deficient mice after treatment with the oral factor Xa inhibitor rivaroxaban","volume":"2011","author":"Zhou","year":"2011","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.atherosclerosis.2020.06.003_bib68","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1477-9560-11-11","article-title":"Laboratory assessment of rivaroxaban: a review","volume":"11","author":"Samama","year":"2013","journal-title":"Thromb. J."},{"key":"10.1016\/j.atherosclerosis.2020.06.003_bib69","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1038\/s41598-019-40602-w","article-title":"Targeting coagulation factor Xa promotes regression of advanced atherosclerosis in apolipoprotein-E deficient mice","volume":"9","author":"Posthuma","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.atherosclerosis.2020.06.003_bib70","doi-asserted-by":"crossref","first-page":"154","DOI":"10.5114\/aoms.2014.40742","article-title":"Thrombin inhibition by dabigatran attenuates atherosclerosis in ApoE deficient mice","volume":"10","author":"Pingel","year":"2014","journal-title":"Arch. Med. Sci."},{"key":"10.1016\/j.atherosclerosis.2020.06.003_bib71","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1124\/jpet.112.194837","article-title":"The effects of direct thrombin inhibition with dabigatran on plaque formation and endothelial function in apolipoprotein E-deficient mice","volume":"343","author":"Lee","year":"2012","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.atherosclerosis.2020.06.003_bib72","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s10557-012-6411-3","article-title":"The beneficial effects of a direct thrombin inhibitor, dabigatran etexilate, on the development and stability of atherosclerotic lesions in apolipoprotein E-deficient mice : dabigatran etexilate and atherosclerosis","volume":"26","author":"Kadoglou","year":"2012","journal-title":"Cardiovasc. Drugs Ther."},{"key":"10.1016\/j.atherosclerosis.2020.06.003_bib73","doi-asserted-by":"crossref","first-page":"5203","DOI":"10.2147\/DDDT.S86969","article-title":"Dabigatran etexilate retards the initiation and progression of atherosclerotic lesions and inhibits the expression of oncostatin M in apolipoprotein E-deficient mice","volume":"9","author":"Preusch","year":"2015","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.atherosclerosis.2020.06.003_bib74","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1161\/01.ATV.0000246797.05781.ad","article-title":"Melagatran reduces advanced atherosclerotic lesion size and may promote plaque stability in apolipoprotein E-deficient mice","volume":"26","author":"Bea","year":"2006","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2020.06.003_bib75","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0055784","article-title":"Genetic and pharmacological modifications of thrombin formation in apolipoprotein e-deficient mice determine atherosclerosis severity and atherothrombosis onset in a neutrophil-dependent manner","volume":"8","author":"Borissoff","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.atherosclerosis.2020.06.003_bib76","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1093\/cvr\/cvr220","article-title":"Thrombomodulin domains attenuate atherosclerosis by inhibiting thrombin-induced endothelial cell activation","volume":"92","author":"Wei","year":"2011","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.atherosclerosis.2020.06.003_bib77","doi-asserted-by":"crossref","first-page":"647","DOI":"10.3389\/fphar.2017.00647","article-title":"Protease-activated receptor-2 deficiency attenuates atherosclerotic lesion progression and instability in apolipoprotein E-deficient mice","volume":"8","author":"Zuo","year":"2017","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.atherosclerosis.2020.06.003_bib78","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1161\/CIRCULATIONAHA.118.033544","article-title":"Protease-activated receptor-2 plays a critical role in vascular inflammation and atherosclerosis in apolipoprotein E-deficient mice","volume":"138","author":"Hara","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2020.06.003_bib79","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1161\/ATVBAHA.117.310082","article-title":"PAR2 (Protease-Activated receptor 2) deficiency attenuates atherosclerosis in mice","volume":"38","author":"Jones","year":"2018","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2020.06.003_bib80","doi-asserted-by":"crossref","first-page":"10574","DOI":"10.1074\/jbc.RA118.003491","article-title":"Protease-activated receptor 1 inhibits cholesterol efflux and promotes atherogenesis via cullin 3-mediated degradation of the ABCA1 transporter","volume":"293","author":"Raghavan","year":"2018","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.atherosclerosis.2020.06.003_bib81","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1161\/ATVBAHA.118.310967","article-title":"Noncanonical matrix metalloprotease 1-protease-activated receptor 1 signaling drives progression of atherosclerosis","volume":"38","author":"Rana","year":"2018","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2020.06.003_bib82","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.devcel.2009.11.014","article-title":"Local protease signaling contributes to neural tube closure in the mouse embryo","volume":"18","author":"Camerer","year":"2010","journal-title":"Dev. Cell"},{"key":"10.1016\/j.atherosclerosis.2020.06.003_bib83","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1161\/01.CIR.95.3.594","article-title":"Tissue factor modulates the thrombogenicity of human atherosclerotic plaques","volume":"95","author":"Toschi","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2020.06.003_bib84","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1161\/01.CIR.99.14.1780","article-title":"Local inhibition of tissue factor reduces the thrombogenicity of disrupted human atherosclerotic plaques: effects of tissue factor pathway inhibitor on plaque thrombogenicity under flow conditions","volume":"99","author":"Badimon","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2020.06.003_bib85","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.jacc.2009.11.051","article-title":"A 2-step mechanism of arterial thrombus formation induced by human atherosclerotic plaques","volume":"55","author":"Reininger","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2020.06.003_bib86","doi-asserted-by":"crossref","first-page":"3190","DOI":"10.1182\/blood-2004-03-0935","article-title":"Hematopoietic cell-derived microparticle tissue factor contributes to fibrin formation during thrombus propagation","volume":"104","author":"Chou","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.atherosclerosis.2020.06.003_bib87","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1189\/jlb.0405193","article-title":"Leukocyte-versus microparticle-mediated tissue factor transfer during arteriolar thrombus development","volume":"78","author":"Gross","year":"2005","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.atherosclerosis.2020.06.003_bib88","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1182\/blood-2004-06-2225","article-title":"Macrovascular thrombosis is driven by tissue factor derived primarily from the blood vessel wall","volume":"105","author":"Day","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.atherosclerosis.2020.06.003_bib89","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1160\/TH04-01-0006","article-title":"The effect of vascular smooth muscle cell-targeted expression of tissue factor pathway inhibitor in a murine model of arterial thrombosis","volume":"92","author":"Pan","year":"2004","journal-title":"Thromb. Haemostasis"},{"key":"10.1016\/j.atherosclerosis.2020.06.003_bib90","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1182\/blood-2007-05-090944","article-title":"Vascular smooth muscle-derived tissue factor is critical for arterial thrombosis after ferric chloride-induced injury","volume":"113","author":"Wang","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.atherosclerosis.2020.06.003_bib91","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1080\/10739680701653517","article-title":"Key role of platelet procoagulant activity in tissue factor-and collagen-dependent thrombus formation in arterioles and venules in vivo differential sensitivity to thrombin inhibition","volume":"15","author":"Kuijpers","year":"2008","journal-title":"Microcirculation"},{"key":"10.1016\/j.atherosclerosis.2020.06.003_bib92","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1161\/01.RES.74.1.56","article-title":"A monoclonal antibody against rabbit tissue factor inhibits thrombus formation in stenotic injured rabbit carotid arteries","volume":"74","author":"Pawashe","year":"1994","journal-title":"Circ. Res."},{"key":"10.1016\/j.atherosclerosis.2020.06.003_bib93","first-page":"57","article-title":"Procoagulant activity on injured arteries and associated thrombi is mediated primarily by the complex of tissue factor and factor VIIa","volume":"7","author":"Speidel","year":"1996","journal-title":"Coron. Artery Dis."},{"key":"10.1016\/j.atherosclerosis.2020.06.003_bib94","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1160\/TH09-06-0400","article-title":"Inhibition of acute vascular thrombosis in chimpanzees by an anti-human tissue factor antibody targeting the factor X binding site","volume":"103","author":"Jiao","year":"2010","journal-title":"Thromb. Haemostasis"},{"key":"10.1016\/j.atherosclerosis.2020.06.003_bib95","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1124\/jpet.103.052779","article-title":"Pharmacological interruption of acute thrombus formation with minimal hemorrhagic complications by a small molecule tissue factor\/factor VIIa inhibitor: comparison to factor Xa and thrombin inhibition in a nonhuman primate thrombosis model","volume":"306","author":"Suleymanov","year":"2003","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.atherosclerosis.2020.06.003_bib96","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1055\/s-0037-1615237","article-title":"Fibrin-rich and platelet-rich thrombus formation on neointima: recombinant tissue factor pathway inhibitor prevents fibrin formation and neointimal development following repeated balloon injury of rabbit aorta","volume":"80","author":"Asada","year":"1998","journal-title":"Thromb. Haemostasis"},{"key":"10.1016\/j.atherosclerosis.2020.06.003_bib97","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1016\/S0735-1097(00)01018-4","article-title":"Inhibition of tissue factor reduces thrombus formation and intimal hyperplasia after porcine coronary angioplasty","volume":"36","author":"Roqu\u00e9","year":"2000","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2020.06.003_bib98","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1538-7836.2004.00547.x","article-title":"Characterization of a tissue factor\/factor VIIa-dependent model of thrombosis in hypercholesterolemic rabbits","volume":"2","author":"Chi","year":"2004","journal-title":"J. Thromb. Haemostasis"},{"key":"10.1016\/j.atherosclerosis.2020.06.003_bib99","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1161\/ATVBAHA.114.303315","article-title":"Factor XII regulates the pathological process of thrombus formation on ruptured plaques","volume":"34","author":"Kuijpers","year":"2014","journal-title":"Arterioscler. Thromb. Vasc. Biol."}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915020302999?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915020302999?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T00:44:20Z","timestamp":1758156260000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915020302999"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":99,"alternative-id":["S0021915020302999"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2020.06.003","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tissue factor in atherosclerosis and atherothrombosis","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2020.06.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}